The Pediatric infectious disease journal · 2026
Challenges and Solutions in Managing Umbilical Myiasis With Sepsis in a Newborn.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Silva Laura Melo, Pasa Morgan Mariana Aparecida, Azevedo Marina Lemos Ramalho de, Silva Pedro Henrique Oliveira, Pereira Neto Antônio Lôbo, Carvalho Vânia Oliveira
Аннотация
BACKGROUND: Myiasis is caused by the infestation of fly larvae and occurs more frequently in tropical, rural and low socioeconomic areas. We report a rare case of umbilical myiasis in a neonate, complicated by sepsis caused by Staphylococcus aureus .
CASE REPORT: The patient, born in a vulnerable family, presented on the fourth day of life with erythema in the umbilical region, accompanied by serous drainage and visible larvae. Immobilization and manual removal of the larvae were attempted 3 times but proved ineffective. On the 10th day of hospitalization, oral ivermectin (200 μg/kg) was administered. Two days after initiating the medication, no larvae were observed, and no adverse events occurred. The delay in initiating treatment, due to insufficient robust evidence of ivermectin's safety in children weighing less than 15 kg, contributed to complications and prolonged hospitalization.
DISCUSSION: Umbilical myiasis reflects inadequate hygiene conditions and socioeconomic vulnerability. Traditional management in children under 15 kg includes occlusion with Vaseline or similar substances and mechanical removal of the larvae. This report emphasizes the critical need for safety studies on ivermectin's use in children weighing less than 15 kg, considering its potential to significantly improve the management of neglected parasitic diseases.
CASE REPORT: The patient, born in a vulnerable family, presented on the fourth day of life with erythema in the umbilical region, accompanied by serous drainage and visible larvae. Immobilization and manual removal of the larvae were attempted 3 times but proved ineffective. On the 10th day of hospitalization, oral ivermectin (200 μg/kg) was administered. Two days after initiating the medication, no larvae were observed, and no adverse events occurred. The delay in initiating treatment, due to insufficient robust evidence of ivermectin's safety in children weighing less than 15 kg, contributed to complications and prolonged hospitalization.
DISCUSSION: Umbilical myiasis reflects inadequate hygiene conditions and socioeconomic vulnerability. Traditional management in children under 15 kg includes occlusion with Vaseline or similar substances and mechanical removal of the larvae. This report emphasizes the critical need for safety studies on ivermectin's use in children weighing less than 15 kg, considering its potential to significantly improve the management of neglected parasitic diseases.